Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03360435 · ClinicalTrials.gov registry record
Absorption of Transdermal Vitamins in Post Bariatric Surgery Patients
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 99
- Enrollment target
NCT03360435: Completed study, sponsored by University of Florida.
NCT03360435 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 99 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03360435 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 99 participants
- Enrollment target
Study Summary
Patients undergoing bariatric surgery often develop new vitamin and/or mineral deficiencies or exacerbate prior deficiencies after surgery. Several bariatric supplement products exist including oral tablets and transdermal patches. The purpose of this study is to observe the concentrations of serum micronutrients and determine how many deficiencies develop in patients who use a transdermal patch.
Primary Outcome
The primary end point is the percentage of participants who have two or more deficiencies of vitamins B1, B6, B12, folate, D, zinc, calcium, copper, and iron one year after bariatric surgery after using the Patch MD™ MultiVitamin Plus transdermal patch for supplementation.
Interventions
- DIETARY_SUPPLEMENT Patch MD MultiVitamin Plus patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2017-12-15 |
| Est. Completion | 2021-07-07 |
What the finished NCT03360435 record still lists
NCT03360435 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 99 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Patch MD MultiVitamin Plus patch is the first listed.
NCT03360435 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03360435 about?
NCT03360435 is a clinical study titled "Absorption of Transdermal Vitamins in Post Bariatric Surgery Patients". Patients undergoing bariatric surgery often develop new vitamin and/or mineral deficiencies or exacerbate prior deficiencies after surgery. Several bariatric supplement products exist including oral tablets and transdermal patches. The purpose of this study is to observe the concentrations of serum ...
What is the current status of trial NCT03360435?
This trial is currently completed. The enrollment target is 99 participants. The study started on 2017-12-15. Estimated completion is 2021-07-07.
What interventions are being tested in trial NCT03360435?
The interventions under investigation include: Patch MD MultiVitamin Plus patch (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03360435?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI